BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hatton GB, Madla CM, Rabbie SC, Basit AW. All disease begins in the gut: Influence of gastrointestinal disorders and surgery on oral drug performance. Int J Pharm 2018;548:408-22. [PMID: 29969711 DOI: 10.1016/j.ijpharm.2018.06.054] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Trenfield SJ, Madla CM, Basit AW, Gaisford S. The Shape of Things to Come: Emerging Applications of 3D Printing in Healthcare. In: Basit AW, Gaisford S, editors. 3D Printing of Pharmaceuticals. Cham: Springer International Publishing; 2018. pp. 1-19. [DOI: 10.1007/978-3-319-90755-0_1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
2 Lu M, Xuan S, Wang Z. Oral microbiota: A new view of body health. Food Science and Human Wellness 2019;8:8-15. [DOI: 10.1016/j.fshw.2018.12.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
3 Vinarov Z, Abrahamsson B, Artursson P, Batchelor H, Berben P, Bernkop-Schnürch A, Butler J, Ceulemans J, Davies N, Dupont D, Flaten GE, Fotaki N, Griffin BT, Jannin V, Keemink J, Kesisoglou F, Koziolek M, Kuentz M, Mackie A, Meléndez-Martínez AJ, McAllister M, Müllertz A, O'Driscoll CM, Parrott N, Paszkowska J, Pavek P, Porter CJH, Reppas C, Stillhart C, Sugano K, Toader E, Valentová K, Vertzoni M, De Wildt SN, Wilson CG, Augustijns P. Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP network. Adv Drug Deliv Rev 2021;171:289-331. [PMID: 33610694 DOI: 10.1016/j.addr.2021.02.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
4 Coombes Z, Yadav V, McCoubrey LE, Freire C, Basit AW, Conlan RS, Gonzalez D. Progestogens Are Metabolized by the Gut Microbiota: Implications for Colonic Drug Delivery. Pharmaceutics 2020;12:E760. [PMID: 32806503 DOI: 10.3390/pharmaceutics12080760] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
5 Yadav V, Mai Y, McCoubrey LE, Wada Y, Tomioka M, Kawata S, Charde S, Basit AW. 5-Aminolevulinic Acid as a Novel Therapeutic for Inflammatory Bowel Disease. Biomedicines 2021;9:578. [PMID: 34065300 DOI: 10.3390/biomedicines9050578] [Reference Citation Analysis]
6 Pinto LA, Corá LA, Rodrigues GS, Prospero AG, Soares GA, de Andreis U, de Arruda Miranda JR. Pharmacomagnetography to evaluate the performance of magnetic enteric-coated tablets in the human gastrointestinal tract. Eur J Pharm Biopharm 2021;161:50-5. [PMID: 33592280 DOI: 10.1016/j.ejpb.2021.02.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Drewes AM, Olesen AE, Farmer AD, Szigethy E, Rebours V, Olesen SS. Gastrointestinal pain. Nat Rev Dis Primers. 2020;6:1. [PMID: 31907359 DOI: 10.1038/s41572-019-0135-7] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 16.0] [Reference Citation Analysis]
8 Teruel AH, Gonzalez-Alvarez I, Bermejo M, Merino V, Marcos MD, Sancenon F, Gonzalez-Alvarez M, Martinez-Mañez R. New Insights of Oral Colonic Drug Delivery Systems for Inflammatory Bowel Disease Therapy. Int J Mol Sci 2020;21:E6502. [PMID: 32899548 DOI: 10.3390/ijms21186502] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
9 Walton GE, Gibson GR, Hunter KA. Mechanisms linking the human gut microbiome to prophylactic and treatment strategies for COVID-19. Br J Nutr 2021;126:219-27. [PMID: 33032673 DOI: 10.1017/S0007114520003980] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
10 McCoubrey LE, Elbadawi M, Orlu M, Gaisford S, Basit AW. Harnessing machine learning for development of microbiome therapeutics. Gut Microbes 2021;13:1-20. [PMID: 33522391 DOI: 10.1080/19490976.2021.1872323] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
11 Goyanes A, Allahham N, Trenfield SJ, Stoyanov E, Gaisford S, Basit AW. Direct powder extrusion 3D printing: Fabrication of drug products using a novel single-step process. Int J Pharm 2019;567:118471. [PMID: 31252147 DOI: 10.1016/j.ijpharm.2019.118471] [Cited by in Crossref: 79] [Cited by in F6Publishing: 67] [Article Influence: 26.3] [Reference Citation Analysis]
12 Zhao P, Xia X, Xu X, Leung KKC, Rai A, Deng Y, Yang B, Lai H, Peng X, Shi P, Zhang H, Chiu PWY, Bian L. Nanoparticle-assembled bioadhesive coacervate coating with prolonged gastrointestinal retention for inflammatory bowel disease therapy. Nat Commun 2021;12:7162. [PMID: 34887414 DOI: 10.1038/s41467-021-27463-6] [Reference Citation Analysis]
13 Varum F, Freire AC, Fadda HM, Bravo R, Basit AW. A dual pH and microbiota-triggered coating (Phloral™) for fail-safe colonic drug release. Int J Pharm 2020;583:119379. [PMID: 32360546 DOI: 10.1016/j.ijpharm.2020.119379] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
14 Varum F, Freire AC, Bravo R, Basit AW. OPTICORE™, an innovative and accurate colonic targeting technology. Int J Pharm 2020;583:119372. [PMID: 32344022 DOI: 10.1016/j.ijpharm.2020.119372] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
15 Effinger A, M O'Driscoll C, McAllister M, Fotaki N. Gastrointestinal diseases and their impact on drug solubility: Ulcerative Colitis. Eur J Pharm Sci 2020;152:105458. [PMID: 32645424 DOI: 10.1016/j.ejps.2020.105458] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Awad A, Trenfield SJ, Gaisford S, Basit AW. 3D printed medicines: A new branch of digital healthcare. Int J Pharm 2018;548:586-96. [PMID: 30033380 DOI: 10.1016/j.ijpharm.2018.07.024] [Cited by in Crossref: 110] [Cited by in F6Publishing: 90] [Article Influence: 27.5] [Reference Citation Analysis]
17 Hatton GB, Madla CM, Rabbie SC, Basit AW. Gut reaction: impact of systemic diseases on gastrointestinal physiology and drug absorption. Drug Discov Today 2019;24:417-27. [PMID: 30453059 DOI: 10.1016/j.drudis.2018.11.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
18 Porat D, Azran C, Mualem Y, Vainer E, Gibori R, Vaynshtein J, Dukhno O, Dahan A. Lamotrigine therapy in patients after bariatric surgery: Potentially hampered solubility and dissolution. Int J Pharm 2021;:121298. [PMID: 34793937 DOI: 10.1016/j.ijpharm.2021.121298] [Reference Citation Analysis]
19 Awad A, Madla CM, McCoubrey LE, Ferraro F, Gavins FKH, Buanz A, Gaisford S, Orlu M, Siepmann F, Siepmann J, Basit AW. Clinical translation of advanced colonic drug delivery technologies. Adv Drug Deliv Rev 2021;181:114076. [PMID: 34890739 DOI: 10.1016/j.addr.2021.114076] [Reference Citation Analysis]
20 Meldgaard T, Keller J, Olesen AE, Olesen SS, Krogh K, Borre M, Farmer A, Brock B, Brock C, Drewes AM. Pathophysiology and management of diabetic gastroenteropathy. Therap Adv Gastroenterol. 2019;12:1756284819852047. [PMID: 31244895 DOI: 10.1177/1756284819852047] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
21 Hua S, Lye EC. Impact of gastric and bowel surgery on gastrointestinal drug delivery. Drug Deliv Transl Res 2022. [PMID: 35585472 DOI: 10.1007/s13346-022-01179-6] [Reference Citation Analysis]
22 Stillhart C, Vučićević K, Augustijns P, Basit AW, Batchelor H, Flanagan TR, Gesquiere I, Greupink R, Keszthelyi D, Koskinen M, Madla CM, Matthys C, Miljuš G, Mooij MG, Parrott N, Ungell A, de Wildt SN, Orlu M, Klein S, Müllertz A. Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review. European Journal of Pharmaceutical Sciences 2020;147:105280. [DOI: 10.1016/j.ejps.2020.105280] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 18.5] [Reference Citation Analysis]
23 Seoane-Viaño I, Gómez-Lado N, Lázare-Iglesias H, Barreiro-de Acosta M, Silva-Rodríguez J, Luzardo-Álvarez A, Herranz M, Otero-Espinar F, Antúnez-López JR, Lamas MJ, Aguiar P, Fernández-Ferreiro A, Ruibal Á. Longitudinal PET/CT evaluation of TNBS-induced inflammatory bowel disease rat model. Int J Pharm 2018;549:335-42. [PMID: 30081226 DOI: 10.1016/j.ijpharm.2018.08.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
24 Effinger A, O'Driscoll CM, McAllister M, Fotaki N. Gastrointestinal diseases and their impact on drug solubility: Crohn's disease. Eur J Pharm Sci 2020;152:105459. [PMID: 32649984 DOI: 10.1016/j.ejps.2020.105459] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Bisharat L, Barker SA, Narbad A, Craig DQ. In vitro drug release from acetylated high amylose starch-zein films for oral colon-specific drug delivery. International Journal of Pharmaceutics 2019;556:311-9. [DOI: 10.1016/j.ijpharm.2018.12.021] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 4.7] [Reference Citation Analysis]
26 Fragomeno M, Assad S, Mobili P, Peruzzo PJ, Minnaard J, Pérez PF. Biomodification of acenocoumarol by bifidobacteria. FEMS Microbiol Lett 2021;368:fnab125. [PMID: 34529059 DOI: 10.1093/femsle/fnab125] [Reference Citation Analysis]
27 Coombes Z, Plant K, Freire C, Basit AW, Butler P, Conlan RS, Gonzalez D. Progesterone Metabolism by Human and Rat Hepatic and Intestinal Tissue. Pharmaceutics 2021;13:1707. [PMID: 34684000 DOI: 10.3390/pharmaceutics13101707] [Reference Citation Analysis]
28 Elbadawi M, McCoubrey LE, Gavins FKH, Ong JJ, Goyanes A, Gaisford S, Basit AW. Harnessing artificial intelligence for the next generation of 3D printed medicines. Adv Drug Deliv Rev 2021;175:113805. [PMID: 34019957 DOI: 10.1016/j.addr.2021.05.015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 16.0] [Reference Citation Analysis]
29 Sanders ME, Merenstein DJ, Reid G, Gibson GR, Rastall RA. Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nat Rev Gastroenterol Hepatol. 2019;16:605-616. [PMID: 31296969 DOI: 10.1038/s41575-019-0173-3] [Cited by in Crossref: 251] [Cited by in F6Publishing: 218] [Article Influence: 83.7] [Reference Citation Analysis]
30 Luo Z, Yu G, Han X, Liu Y, Wang G, Li X, Yang H, Sun W. Exploring the Active Components of Simotang Oral Liquid and Their Potential Mechanism of Action on Gastrointestinal Disorders by Integrating Ultrahigh-Pressure Liquid Chromatography Coupled with Linear Ion Trap-Orbitrap Analysis and Network Pharmacology. ACS Omega 2021;6:2354-66. [PMID: 33521474 DOI: 10.1021/acsomega.0c05680] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Hua S. Advances in Oral Drug Delivery for Regional Targeting in the Gastrointestinal Tract - Influence of Physiological, Pathophysiological and Pharmaceutical Factors. Front Pharmacol 2020;11:524. [PMID: 32425781 DOI: 10.3389/fphar.2020.00524] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]
32 Jarau M, Macinnes JI, Lumsden JS. Erythromycin and florfenicol treatment of rainbow trout Oncorhynchus mykiss (Walbaum) experimentally infected with Flavobacterium psychrophilum. J Fish Dis 2019;42:325-34. [DOI: 10.1111/jfd.12944] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
33 Hua S. Physiological and Pharmaceutical Considerations for Rectal Drug Formulations. Front Pharmacol 2019;10:1196. [PMID: 31680970 DOI: 10.3389/fphar.2019.01196] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]